Drivers and regulators of humoral innate immune responses to infection and cancer
•Pathogens and tumor cells develop complement evasion mechanisms.•B-1 B cells produce critical natural antibodies in the infectious and tumorigenic immune response.•Natural antibodies recognize and opsonize microbial and cancer antigens. The complement cascade consists of cell bound and serum protei...
Saved in:
Published in | Molecular immunology Vol. 121; pp. 99 - 110 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •Pathogens and tumor cells develop complement evasion mechanisms.•B-1 B cells produce critical natural antibodies in the infectious and tumorigenic immune response.•Natural antibodies recognize and opsonize microbial and cancer antigens.
The complement cascade consists of cell bound and serum proteins acting together to protect the host from pathogens, remove cancerous cells and effectively links innate and adaptive immune responses. Despite its usefulness in microbial neutralization and clearance of cancerous cells, excessive complement activation causes an immune imbalance and tissue damage in the host. Hence, a series of complement regulatory proteins present at a higher concentration in blood plasma and on cell surfaces tightly regulate the cascade. The complement cascade can be initiated by B-1 B cell production of natural antibodies. Natural antibodies arise spontaneously without any known exogenous antigenic or microbial stimulus and protect against invading pathogens, clear apoptotic cells, provide tissue homeostasis, and modulate adaptive immune functions. Natural IgM antibodies recognize microbial and cancer antigens and serve as an activator of complement mediated lysis. This review will discuss advances in complement activation and regulation in bacterial and viral infections, and cancer. We will also explore the crosstalk of natural antibodies with bacterial populations and cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Co-first authors |
ISSN: | 0161-5890 1872-9142 1872-9142 |
DOI: | 10.1016/j.molimm.2020.03.005 |